Tempus AI (NASDAQ:TEM) Trading 1.3% Higher - What's Next?

Key Points

• Tempus AI stock price increased by 1.3% during mid-day trading, reaching $88.24 with a notable trading volume of 17,635,744 shares, significantly higher than its average volume.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Tempus AI, with an average price target of $70.17, reflecting optimism about the company's financial performance.
• In recent insider trading, CEO Eric P. Lefkofsky sold 332,500 shares for over $24 million, indicating a 3.49% reduction in his stake in the company.

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) was up 1.3% during mid-day trading on Friday . The company traded as high as $90.97 and last traded at $88.24. Approximately 17,635,744 shares were traded during mid-day trading, an increase of 45% from the average daily volume of 12,200,312 shares. The stock had previously closed at $87.07.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on TEM shares. Needham & Company LLC reissued a "buy" rating and issued a $70.00 price objective on shares of Tempus AI in a research note on Friday, August 8th. Guggenheim increased their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Morgan Stanley raised their target price on shares of Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research note on Tuesday, August 12th. HC Wainwright raised their target price on shares of Tempus AI from $90.00 to $98.00 and gave the company a "buy" rating in a research note on Friday, September 12th. Finally, Piper Sandler reaffirmed a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Seven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, Tempus AI presently has an average rating of "Moderate Buy" and an average price target of $70.17.

Tempus AI Stock Up 1.3%

The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. The company's 50-day simple moving average is $70.46 and its 200 day simple moving average is $60.69. The firm has a market cap of $15.33 billion, a P/E ratio of -74.15 and a beta of 5.08.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The business had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. During the same quarter last year, the business earned ($6.86) earnings per share. Tempus AI's quarterly revenue was up 89.5% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Transactions at Tempus AI

In other news, CAO Ryan M. Bartolucci sold 1,904 shares of the firm's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $142,133.60. Following the completion of the sale, the chief accounting officer owned 45,895 shares in the company, valued at approximately $3,426,061.75. This trade represents a 3.98% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO James William Rogers sold 7,528 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $561,965.20. Following the completion of the sale, the chief financial officer owned 138,473 shares of the company's stock, valued at $10,337,009.45. This trade represents a 5.16% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 601,787 shares of company stock worth $42,492,268. 26.27% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Tempus AI

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Concord Wealth Partners increased its position in Tempus AI by 308.0% during the 2nd quarter. Concord Wealth Partners now owns 408 shares of the company's stock valued at $26,000 after purchasing an additional 308 shares during the period. Allworth Financial LP increased its position in Tempus AI by 5,000.0% during the 2nd quarter. Allworth Financial LP now owns 459 shares of the company's stock valued at $29,000 after purchasing an additional 450 shares during the period. Cherry Tree Wealth Management LLC purchased a new position in Tempus AI during the 1st quarter valued at about $31,000. SouthState Corp increased its position in Tempus AI by 3,761.5% during the 2nd quarter. SouthState Corp now owns 502 shares of the company's stock valued at $32,000 after purchasing an additional 489 shares during the period. Finally, University of Texas Texas AM Investment Management Co. purchased a new position in Tempus AI during the 1st quarter valued at about $33,000. Institutional investors own 24.22% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.